Silvia S Pierangeli Selected Research

Silvia S Pierangeli Research Topics

Disease

29	Thrombosis (Thrombus) 04/2015 - 01/2002
28	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2016 - 01/2002
9	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2016 - 08/2002
7	Autoimmune Diseases (Autoimmune Disease) 04/2015 - 11/2007
6	Thrombophilia 06/2011 - 01/2004
3	Thrombocytopenia (Thrombopenia) 09/2006 - 01/2002
1	Necrosis 06/2014
1	Rheumatic Diseases (Rheumatism) 01/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2013
1	Atherosclerosis 05/2013
1	Vascular System Injuries 10/2009
1	Infections 01/2003
1	Communicable Diseases (Infectious Diseases) 01/2003
1	Opportunistic Infections (Opportunistic Infection) 08/2002
1	Neoplasms (Cancer) 08/2002

Drug/Important Bio-Agent (IBA)

17	Antiphospholipid AntibodiesIBA 09/2016 - 02/2002
14	AntibodiesIBA 09/2016 - 01/2002
10	Immunoglobulin G (IgG)IBA 04/2015 - 08/2002
7	Thromboplastin (Tissue Factor)IBA 04/2015 - 10/2007
5	Monoclonal AntibodiesIBA 01/2014 - 01/2004
5	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 05/2013 - 09/2006
4	Glycoproteins (Glycoprotein)IBA 09/2016 - 01/2011
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2013 - 09/2006
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 09/2006 - 03/2002
3	Peptides (Polypeptides)IBA 05/2004 - 02/2002
2	Immunoglobulin A (IgA)IBA 09/2016 - 12/2013
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2016 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 12/2014 - 06/2014
2	AutoantibodiesIBA 01/2014 - 08/2002
2	Anticardiolipin AntibodiesIBA 06/2012 - 04/2008
2	Immunoglobulin M (IgM)IBA 01/2012 - 06/2007
2	beta 2-Glycoprotein I (Apolipoprotein H)IBA 10/2009 - 04/2008
2	Fluvastatin FDA Link 09/2009 - 11/2003
2	Complement System Proteins (Complement)IBA 07/2005 - 06/2005
1	LipidsIBA 01/2016
1	AldehydesIBA 01/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014
1	InterferonsIBA 06/2014
1	InterleukinsIBA 06/2014
1	CD40 Ligand (CD40L)IBA 06/2014
1	Biomarkers (Surrogate Marker)IBA 06/2014
1	Immunoglobulins (Immunoglobulin)IBA 01/2014
1	AntigensIBA 01/2014
1	low density lipoprotein receptor-related protein 8IBA 01/2011
1	Free RadicalsIBA 07/2010
1	NF-kappa B (NF-kB)IBA 06/2010
1	p38 Mitogen-Activated Protein KinasesIBA 06/2010
1	AutoantigensIBA 04/2008
1	LipopolysaccharidesIBA 10/2007
1	Toll-Like Receptor 4IBA 10/2007
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2007
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 06/2007
1	Anaphylatoxin C5a ReceptorIBA 06/2007
1	Complement C3 (C3 Complement)IBA 07/2005
1	CoagulantsIBA 06/2005
1	Bacterial AntigensIBA 05/2004
1	peptide AIBA 05/2004
1	B-Cell Activating FactorIBA 08/2002
1	Antimalarials (Antimalarial Agents)IBA 03/2002

Therapy/Procedure

6	Therapeutics 01/2012 - 01/2004
3	Operative Surgical Procedures 12/2013 - 05/2004
2	Injections 10/2009 - 07/2005
1	Transcranial Direct Current Stimulation 11/2014